MAPT and Parkinson disease: By using other panels of antibodies or adding fluorescence channels, CNNs could be trained to distinguish between mature and immature OSNs; to identify sustentacular cells and ciliated respiratory cells; to segment lymphatic vessels; and to detect pathological accumulations like α-synuclein (Parkinson’s) and phosphorylated tau (Alzheimer’s).